(MDT) Medtronic - Ratings and Ratios

Medtronic plc is a global leader in medical technology, specializing in device-based therapies that address a wide range of chronic and acute health conditions. The companys portfolio spans four primary segments: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The Cardiovascular Portfolio includes advanced solutions for heart rhythm disorders, structural heart disease, and coronary interventions, such as implantable pacemakers, defibrillators, and transcatheter valves. The Neuroscience Portfolio offers therapies for neurological and spinal disorders, including spinal cord stimulation, implantable drug delivery systems, and nerve ablation technologies. The Medical Surgical Portfolio focuses on surgical innovations, including stapling devices, robotic-assisted surgery products, and patient monitoring systems. The Diabetes Operating Unit provides integrated diabetes management solutions, such as insulin pumps, continuous glucose monitoring systems, and smart insulin pens. Medtronic has been at the forefront of medical innovation since its founding in 1949 and is headquartered in Galway, Ireland.

Medtronics commitment to innovation is evident in its continuous development of cutting-edge medical technologies. For instance, its TYRX absorbable antibacterial envelope is designed to reduce infections in patients with implantable devices. Additionally, the company has made significant strides in remote patient monitoring, enabling healthcare providers to manage chronic conditions more effectively. Its AI-powered surgical video and analytics platform is another example of how Medtronic integrates advanced technologies to improve surgical outcomes. The companys diverse product range and focus on patient-centered solutions have established it as a key player in the global healthcare industry.

Ticker Symbol: MDT Exchange: NYSE Type: common stock Country Origin: Ireland GICS Sub Industry: Health Care Equipment Average Volume 20d: 7561770 Last Price: 82.60 SMA 20: 85.80 SMA 50: 88.80 SMA 200: 85.28 ATR: 2.38 Market Cap: 106322.57M USD P/E: 25.27 P/E Forward: 14.16 P/B: 2.15 P/S: 3.20 RoE: 8.63 3-Month Forecast: Based on the technical and fundamental data, Medtronics stock price is expected to remain under pressure in the near term. The SMA 20 and SMA 50 are in a bearish alignment, with the stock trading below both averages. The ATR of 2.38 suggests moderate volatility, and the recent close of 82.60 is below the SMA 200 of 85.28, indicating potential resistance at higher levels. Fundamentally, while the forward P/E of 14.16 signals undervaluation, the current P/E of 25.27 reflects elevated valuations relative to earnings. The market cap of 106.3B USD underscores the companys size and stability, but near-term price action is likely to be range-bound between 78 and 88, with a downside bias due to the bearish moving average crossover.